Nexien Biopharma

Nexien Biopharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nexien Biopharma (NXEN) as of Nov 11, 2026 is -156,000.00 USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -283,000.00 USD — a change of -44.88% (higher).

EBITDA

-156,000.00USD

YoY

-44.88%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nexien Biopharma is 2024 -156,000.00 USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nexien Biopharma was 2023 -283,000.00 USD. It decreases by -44.88% higher compared to the previous year.

The Nexien Biopharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
-258,653.00 USD
Jan 1, 2018
-1.28 M USD
Jan 1, 2019
-3.93 M USD
Jan 1, 2020
-2.64 M USD
Jan 1, 2021
-1.84 M USD
Jan 1, 2022
-563,992.00 USD
Jan 1, 2023
-283,000.00 USD
Jan 1, 2024
-156,000.00 USD
The Nexien Biopharma EBITDA history
YEAREBITDAYoY
-156,000.00USD-44.88%
-283,000.00USD-49.82%
-563,992.00USD-69.41%
-1.84 MUSD-30.08%
-2.64 MUSD-32.95%
-3.93 MUSD+206.50%
-1.28 MUSD+396.11%
-258,653.00USD+1,481.98%
-16,350.00USD-64.97%
-46,675.00USD+9,142.57%
-505.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Nexien Biopharma Stock analysis

What does Nexien Biopharma do? Nexien Biopharma Inc is an American company that focuses on researching and developing therapies for rare diseases. It was founded in 2016 by experienced leaders in the pharmaceutical and biotech industry and is headquartered in Irvine, California. Nexien Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nexien Biopharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nexien Biopharma is -156,000.00 USD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nexien Biopharma changed from -283,000.00 USD to -156,000.00 USD, representing a -44.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Nexien Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Nexien Biopharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Nexien Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Nexien Biopharma